Experts examine the reasoning behind a steep rise in tick-borne illnesses, such as Lyme disease, in the United States and discuss the best ways to thwart this serious public health threat.
Investigators conducted sought to determine the efficacy of artemether-lumefantrine against Plasmodium falciparum and if treatment outcomes are linked to genetic traits in the Pfkelch13 alleles.
Study authors searched medical databases to identify factors that could be detected in the febrile phase associated with progression to severe dengue disease.
Researchers used a retrospective survey to associate sexual behavior during the Zika virus epidemic to better understand the disease burden of sexually transmitted Zika virus.
TicoVac is an inactivated whole virus vaccine developed using a master ‘seed’ virus that is similar to the tick-borne encephalitis virus found in nature.
Quantitative MRI with brain volume assessment and ADC histogram analyses were performed for the first time in 65 patients with cerebral malaria to compare disease signatures of children and adults as well as fatal and nonfatal cases.
As a ZPIV vaccine had proved to be well tolerated and immunogenic at up to 8 weeks of follow-up, investigators evaluated the safety and immunogenicity of ZPIV at up to 52 weeks of follow-up using a standard or accelerated vaccination schedules.
Findings in a case report in Morbidity and Mortality Weekly Report suggest the possibility that exposure to Trypanosoma cruzi occurred locally in Missouri.
Researchers at the University of California San Diego have identified a target gene in mosquitos that renders the insects completely refractory to all 4 serotypes of the dengue virus and thus, incapable of transmitting the virus to humans, according to study results published in PLoS Pathogens.1 Dengue fever is caused by infection with 1 of…
Researchers evaluated the frequency of polyautoimmunity and its associated factors in a large retrospective cohort of patients with systemic lupus erythematosus.
Study data demonstrates an early benefit to receiving Japanese Encephalitis vaccination prior to CYD-TDV in terms of higher overall anti-dengue virus neutralizing titers, although this benefit appears to wane after several months.
